Setrobuvir

From WikiMD.org
Jump to navigation Jump to search

Setrobuvir

Setrobuvir (pronounced: set-ro-bu-vir) is an experimental antiviral drug that is primarily used in the treatment of Hepatitis C. It is a non-nucleoside NS5B polymerase inhibitor, which means it works by inhibiting the replication of the Hepatitis C virus.

Etymology

The name "Setrobuvir" is derived from the drug's mechanism of action. "Setro" is a prefix used in pharmacology to denote drugs that inhibit or block a certain action, while "buvir" is a suffix commonly used for antiviral drugs.

Mechanism of Action

Setrobuvir works by inhibiting the NS5B RNA-dependent RNA polymerase, an essential protein for the replication of the Hepatitis C virus. By blocking this protein, Setrobuvir prevents the virus from replicating and spreading within the body.

Related Terms

Side Effects

Like all medications, Setrobuvir can cause side effects. The most common side effects include fatigue, headache, and nausea. More serious side effects can include liver damage and severe allergic reactions.

Clinical Trials

Setrobuvir has undergone several clinical trials to test its efficacy and safety in treating Hepatitis C. The results of these trials have been promising, with many patients showing a significant reduction in viral load.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski